sellWeak cluster of 510b5-1 plan
James S Cox sold $451k of CWAN
Chief Financial Officer at Clearwater Analytics Holdings, Inc.. 18,700 shares at an average of $24.14, traded Jan 15, 2026, filed Jan 20, 2026.
Warning score
19Value
$451k
18,700 shares
Holdings after
395,697
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +17Trade size$451k at market
- 0Share of holdings soldSold 4.5% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001441361-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | MOption exercise Class A Common Stock10b5-1 | +3,499 | $4.40 | $15k | 404,196 | Jan 20, 2026 |
| Jan 15, 2026 | MOption exercise Class A Common Stock10b5-1 | +18,486 | $4.40 | $81k | 422,682 | Jan 20, 2026 |
| Jan 15, 2026 | MOption exercise Class A Common Stock10b5-1 | +12,125 | $4.40 | $53k | 434,807 | Jan 20, 2026 |
| Jan 15, 2026 | FTax withholding Class A Common Stock10b5-1 | -2,094 | $24.14 | $51k | 432,713 | Jan 20, 2026 |
| Jan 15, 2026 | FTax withholding Class A Common Stock10b5-1 | -7,255 | $24.14 | $175k | 425,458 | Jan 20, 2026 |
| Jan 15, 2026 | FTax withholding Class A Common Stock10b5-1 | -11,061 | $24.14 | $267k | 414,397 | Jan 20, 2026 |
| Jan 15, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,405 | $24.14 | $34k | 412,992 | Jan 20, 2026 |
| Jan 15, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -4,870 | $24.14 | $118k | 408,122 | Jan 20, 2026 |
| Jan 15, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -7,425 | $24.14 | $179k | 400,697 | Jan 20, 2026 |
| Jan 15, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -5,000 | $24.14 | $121k | 395,697 | Jan 20, 2026 |
| Jan 15, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,499 | $0.00 | $0 | 141,399 | Jan 20, 2026 |
| Jan 15, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,486 | $0.00 | $0 | 122,913 | Jan 20, 2026 |
| Jan 15, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,125 | $0.00 | $0 | 110,788 | Jan 20, 2026 |
Related signals
Other insiders at Clearwater Analytics Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 68Notable | Clearwater Analytics Holdings, Inc. | D Scott Mackesy director | $15M 633,879 shares | -100% | |
| 16Weak | Clearwater Analytics Holdings, Inc. | Souvik Das Chief Technology Officer | $244k 10,000 shares | -5% | |
| 8Weak | Clearwater Analytics Holdings, Inc. | Souvik Das Chief Technology Officer | $243k 10,000 shares | -5% | |
| 12Weak | Clearwater Analytics Holdings, Inc. | James S Cox Chief Financial Officer | $450k 18,700 shares | -4% | |
| 23Weak | Clearwater Analytics Holdings, Inc. | Souvik Das Chief Technology Officer | $240k 10,000 shares | -5% | |
| 40Moderate | Clearwater Analytics Holdings, Inc. | James S Cox Chief Financial Officer | $515k 21,631 shares | -4% | |
| 50Moderate | Clearwater Analytics Holdings, Inc. | Sandeep Sahai Chief Executive Officer | $1.2M 51,967 shares | -4% | |
| 37Weak | Clearwater Analytics Holdings, Inc. | Scott Stanley Erickson Chief Revenue Officer | $447k 18,790 shares | -11% | |
| 30Weak | Clearwater Analytics Holdings, Inc. | Souvik Das Chief Technology Officer | $350k 14,686 shares | -7% | |
| 32Weak | Clearwater Analytics Holdings, Inc. | Subi Sethi Chief Client Officer | $473k 19,858 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.